(New York, 12 August 2013)—K2 Intelligence, a leading investigative and risk analytics services firm, announced today that Thomas Glocer, former chief executive officer of Thomson Reuters Corp., will join as an investor and member of the firm’s board of directors.

“As a recognized leader in the information services industry, Tom brings significant expertise in technology and global M&A. This perspective is extremely important to us as we grow our tech-powered corporate intelligence business,” said Jeremy M. Kroll, CEO and president of K2 Intelligence. “Tom has taken a strong interest in K2 Intelligence since its development and we are pleased to officially welcome him as a board member.”

“Jules and Jeremy Kroll created the modern global intelligence services business and are now innovating again with the K2 Intelligence platform,” said Mr. Glocer. “The challenge of running a major global enterprise today is that C-suite executives are drowning in a sea of big data, but cannot filter the precise, actionable intelligence they need. K2 Intelligence provides that expert filter and focus, along with a suite of innovative analytical tools. I’m very excited to work closely with the management team to help K2 Intelligence expand its tailored investigative solutions to clients globally.”

“As we’ve seen in recent weeks, threats to corporate data are increasingly complex and difficult to detect,” he continued. “No other intelligence firm matches K2 Intelligence’s ability to help companies understand their data, identify internal and external vulnerabilities and prevent fraudulent activity such as insider trading, cybercrime and money laundering.”

Mr. Glocer served as chief executive officer of Thomson Reuters Corp., the leading news and professional information provider, from April 2008 through December 2011. Thomson Reuters was formed upon the acquisition of Reuters Group PLC, where Mr. Glocer became CEO in 2001 following a series of international executive roles.

Before joining Reuters, Mr. Glocer was a mergers and acquisitions lawyer at Davis Polk & Wardwell in New York, Paris, and Tokyo. He is a member of the board of irectors of Merck & Co., Inc., Morgan Stanley, and the Council on Foreign Relations.